Our results fall in line with a study conducted by Kim et al., who showed in multivariate analysis that serum BAFF but not APRIL was an independent prognostic factor for OS and progression-free survival in NHL patients [40]. The gene discussed is TNFSF13; the disease is non-Hodgkin lymphoma.